Q2 2022 Holdings
Filed 2022-08-15 | 80 holdings | $462.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arvinas Inc(ARVN) | COM | 04335A105 | $131.5M | 3,123,300 | 28.5% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $84.4M | 5,991,479 | 18.3% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $51.2M | 4,488,200 | 11.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $47.4M | 125,000 | 10.3% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $45.0M | 6,340,639 | 9.7% |
| Alector Inc(ALEC) | COM | 014442107 | $41.2M | 4,056,548 | 8.9% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $24.8M | 1,330,263 | 5.4% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $19.1M | 895,503 | 4.1% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $15.0M | 1,169,889 | 3.2% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $314.5K | 11,584,280 | 0.1% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $234.4K | 5,183,431 | 0.1% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $215.0K | 2,868,145 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $178.5K | 1,008,628 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $178.4K | 3,197,500 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $152.7K | 7,521,024 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $144.6K | 5,282,416 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $121.7K | 6,638,371 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $85.7K | 3,951,566 | 0.0% |
| ZAI LAB LT(ZLAB) | ADR | 98887Q104 | $84.3K | 2,431,885 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $83.4K | 4,278,069 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $62.4K | 3,723,541 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $60.0K | 1,975,611 | 0.0% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $46.1K | 3,495,943 | 0.0% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $45.0K | 13,896,543 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $43.5K | 1,646,260 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $40.1K | 2,759,505 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $36.9K | 2,634,178 | 0.0% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $28.1K | 4,753,907 | 0.0% |
| Geron Corp(GERN) | COM | 374163103 | $22.0K | 14,168,988 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $18.8K | 2,359,808 | 0.0% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $17.4K | 1,421,319 | 0.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $15.9K | 1,300,000 | 0.0% |
| Exelixis Inc(EXEL)Call | COM | 30161Q104 | $15.8K | 760,000 | 0.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $15.3K | 3,418,068 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $13.9K | 182,783 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $13.2K | 6,117,400 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $12.1K | 690,000 | 0.0% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $10.6K | 1,921,310 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $10.4K | 2,302,065 | 0.0% |
| Akouos Inc | COM | 00973J101 | $9.3K | 1,975,984 | 0.0% |
| Hookipa Pharma Inc | COM | 43906K100 | $8.2K | 5,000,000 | 0.0% |
| Precision Biosciences Inc | COM | 74019P108 | $8.1K | 5,035,971 | 0.0% |
| Surface Oncology Inc | COM | 86877M209 | $7.6K | 4,653,000 | 0.0% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $6.9K | 541,108 | 0.0% |
| Frazier Lifesciences Acqu Co | CL A SHS | G3710A105 | $5.8K | 587,615 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $5.8K | 279,999 | 0.0% |
| Jiya Acquisition Corp | COM CL A | 47760M102 | $4.9K | 500,000 | 0.0% |
| Aligos Therapeutics Inc | COM | 01626L105 | $4.8K | 3,948,360 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $4.6K | 3,500,000 | 0.0% |
| Aveo Pharmaceuticals Inc(0HJQ) | COM NEW | 053588307 | $4.2K | 647,489 | 0.0% |